ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1800

The Role of Nociceptor-Expressed Piezo2 in Nervous System Immune Cell Infiltration in a Mouse Model of Osteoarthritis

Natalie Adamczyk1, Terese Geraghty2, Shingo Ishihara3, alia obeidat2, Jun Li2, Anne-Marie Malfait2 and Rachel Miller1, 1Rush University Medical Center, Chicago, IL, 2Rush University Medical Center, Chicago, 3Rush University, Chicago

Meeting: ACR Convergence 2025

Keywords: innate immunity, Osteoarthritis, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1780–1808) Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Osteoarthritis is one of the leading causes of chronic pain and disability worldwide with 500 million people affected. We have previously reported that nociceptor-conditional Piezo2 knock-out mice (NaV1.8cre-Piezo2fl/fl; Piezo2cko), were protected from pain-related behaviors associated with a surgical model of OA along with spontaneous OA with aging, while joint damage was not affected. Persistent pain development is associated with molecular and cellular changes in the dorsal root ganglia (DRG), which contain the cell bodies of nociceptors as well as various types of non-neuronal cells. Previously, in wild-type mice, we have reported elevated levels of immune cells such as macrophages in the knee-innervating DRG in mouse models of OA, but the link between stimuli sensed by nociceptors in the knee joint and the recruitment of these cells in the DRG is not yet fully elucidated. The objective of the present study was to investigate whether the ion channel Piezo2, expressed by nociceptors, plays a role in these changes within the dorsal root ganglia in a mouse model of osteoarthritis (OA).

Methods: Twelve-week-old WT and Piezo2cko mice of both sexes underwent PMX or sham surgery (n=9-10). Mice were behaviorally assessed pre-operatively and every 4 weeks thereafter for knee hyperalgesia and weight bearing asymmetry. At 13 weeks post operatively knees were used for OA scoring by H&E and Safranin-O. Spinal cords were used for immunofluorescent staining for IBA1+ microglia and GFAP+ astrocytes. Separate cohorts of mice were used to perform flow cytometry or bulk RNAseq on L3-L5 DRG.

Results: Piezo2cko mice of both sexes were protected throughout the time course from knee hyperalgesia and from weight bearing asymmetry development, however Piezo2cko mice developed OA pathology at the same level as WT PMX mice. Piezo2cko PMX mice were protected from innate immune cell influx of NK1.1+ and F4/80+ cells compared to WT PMX mice, which was supported by DRG bulk RNAseq findings. Neuroimmune protection seen at the DRG extends to the CNS as Piezo2cko PMX mice had less activated IBA1+ microglia. In addition, male WT PMX mice displayed an increase in the number of GFAP+ astrocytes compared to Piezo2cko PMX mice. No differences in GFAP+ astrocytes were observed in female mice across the conditions.

Conclusion: Piezo2cko from nociceptors was protective against pain-related behaviors and neuroimmune changes associated with OA in the PMX model in both sexes. However, conditional knockout did not protect from OA joint pathology. Targeting Piezo2 could prove to be a valuable target for inhibiting chronic pain in patients.


Disclosures: N. Adamczyk: None; T. Geraghty: NS Pharma, 3; S. Ishihara: None; a. obeidat: None; J. Li: None; A. Malfait: Asahi Kasei Pharma Corporation, 23andMe, Orion, 2; R. Miller: None.

To cite this abstract in AMA style:

Adamczyk N, Geraghty T, Ishihara S, obeidat a, Li J, Malfait A, Miller R. The Role of Nociceptor-Expressed Piezo2 in Nervous System Immune Cell Infiltration in a Mouse Model of Osteoarthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/the-role-of-nociceptor-expressed-piezo2-in-nervous-system-immune-cell-infiltration-in-a-mouse-model-of-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-nociceptor-expressed-piezo2-in-nervous-system-immune-cell-infiltration-in-a-mouse-model-of-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology